Headline
The latest stories from AHA Today.
The Food and Drug Administration today required certain COVID-19 test developers to evaluate how SARS-CoV-2 mutations impact their test’s performance and update the labeling for the product accordingly.
The Food and Drug Administration late last night amended Pfizer’s emergency use authorization for its COVID-19 vaccine to allow for an additional, booster dose for certain individuals. FDA will authorize a booster shot to be administered six months following a completed two-dose regiment for the…
The AHA’s American Organization for Nursing Leadership affiliate has elected as its 2022 president-elect Deborah Zimmermann.
In AHA’s newest #MyWhy video, nine hospital employees from UAB Medicine in Alabama candidly discuss their COVID-19 vaccine experience, starting with initial hesitancies and navigating misinformation surrounding the vaccine’s development and rumored side effects.
The Joint Commission today named as its next president and CEO effective March 1 Jonathan Perlin, M.D.
The Centers for Medicare & Medicaid Services yesterday began publicly sharing COVID-19 vaccination rates for nursing home staff and residents on its Care Compare website.
The House last night voted 220-211 to pass a continuing resolution that would generally extend current federal funding levels for health care and all other programs through Dec. 3.
The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing examining the impact of COVID-19 on children.
The Food and Drug Administration approved the first biosimilar to treat neovascular age-related macular degeneration, a leading cause of vision loss and blindness for seniors.
The Centers for Medicare & Medicaid Services granted certain Medicare quality reporting exceptions to acute-care hospitals, ambulatory surgical centers, prospective payment system-exempt cancer hospitals, inpatient psychiatric facilities, inpatient rehabilitation facilities, long-term care…